Trailing-twelve-month (TTM) revenue is $54.53 Million with a year-over-year growth of +427.32%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $2,415,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $21,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-27 |
| Q1 FY2026Period ended 2026-03-31 | $51,084,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $1,010,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $54,530,000 |
Current P/S: $419,872,961 market capitalization ÷ $54,530,000 TTM revenue = 7.70x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.01M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T22:18:25.259Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Collaboration | $564,000 | $140M | $14M | $91M | $135M | $10M |
| Collaboration Program, US Rights | N/A | $25M | $14M |
$54.53M
$54.53 Million
+427.32%
vs. $10.34M a year ago (TTM)
+62.57%
5 Year compound annual growth rate
1 Year
+427.32%
3 Year
(1.82%)
5 Year
+62.57%
10 Year
+44.93%
15 Year
+14.67%
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $9.68M | ($125.47M) | (92.83%) |
| 2024 | $135.16M | +$43.79M | +47.92% |
| 2023 | $91.37M | +$37.47M | +69.50% |
| 2022 | $53.91M | ($146.67M) | (73.13%) |
| 2021 | $200.58M | +$199.72M | +23414.30% |
| 2020 |
TTM Growth
+427.32%
3-Year CAGR
(1.82%)
5-Year CAGR
+62.57%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T22:18:25.259Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| N/A |
| N/A |
| License | $289,000 | N/A | N/A | $50,000 | $50,000 | $50,000 |
|---|
| US Rights and Global Rights | N/A | N/A | $85M | N/A | N/A | N/A |
|---|
| $853,000 |
| +$39,000 |
| +4.79% |
| 2019 | $814,000 | ($141,000) | (14.76%) |
| 2018 | $955,000 | ($26.56M) | (96.53%) |
| 2017 | $27.52M | +$26.46M | +2508.44% |
| 2016 | $1.05M | ($552,000) | (34.35%) |
